knowledge -WSS

knowledge

author：fashion 2025-09-29 21:27:20 - browse：476

Physicians Alison Block and Nikki Zite knew what they were getting into when they became abortion providers early in their medical training. Family planning has long been a politicized, divisive area of medicine. And even though they knew that Roe v. Wade — the 1973 Supreme Court case that protected abortion access across the country — was being threatened, it still hit them hard when that ruling was actually overturned in June 2022.

“I thought I was preparing myself. For years I was telling anybody who would listen, ‘Roe is getting overturned! Roe is getting overturned!’ ” Block said. “But just because you say that you know a hard thing is coming, doesn’t mean you’re actually emotionally prepared for that hard thing.”

The pair joined me on the First Opinion Podcast for a conversation about the frustrating and heartbreaking consequences of living in a post-Roe America for providers, trainees, and patients.

Our conversation was based on Block’s recent First Opinion essay, “Brain drain, skills loss, and other unintended consequences of overturning Roe v. Wade.” You can hear more from Block and Zite on the podcast “The Nocturnists.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： How to save PrEP access — and even expand it
Next article： WATCH: Why do our ears pop?

WSS

Hospitals consider fixing cancer drug shortages on their own

Congress may force more Covid

Generate Biomedicines machine learning biotech raises $273M

A new drug could help frostbite victims avoid its ravages

New CMS data security rules will hurt Medicare, Medicaid research

Hospitals consider fixing cancer drug shortages on their own

explore

knowledge

knowledge

What does generative AI mean for health care? We asked experts

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Acelyrin, a rare IPO success, stumbles in its first big test

Anesthesiologist group: stop taking Ozempic before surgery

IRA could hurt research into orphan drugs for rare diseases

Drug repurposing or repositioning? The language matters

Ukraine seeks to reclaim its role as a hub for clinical trials

In Memoriam: Notable people who died in 2023

Ukraine seeks to reclaim its role as a hub for clinical trials

entertainment

What to make of Biden’s latest efforts on cancer research

As AI regulations shape up, health tech startups beg for clarity

Walmart eyes Medicare Advantage provider ChenMed

In 'major milestone,' FDA approves first cell therapy for solid tumors

How to make the FDA’s new prescription one

Pig kidney works a record two months in donated body

focus

hotspot

explore

explore